Fabry Disease: Molecular Basis, Pathophysiology, Diagnostics and Potential Therapeutic Directions

Fabry Disease: Molecular Basis, Pathophysiology, Diagnostics and Potential Therapeutic Directions

Fabry illness (FD) is a lysosomal storage dysfunction (LSD) characterised by the deficiency of α-galactosidase A (α-GalA) and the resultant accumulation of poisonous metabolites corresponding to globotriaosylceramide (Gb3) and globotriaosylsphingosine (lysoGb3). Early prognosis and acceptable well timed therapy of FD Read more